Europe Ai-Based Clinical Trials Solution Provider Market
Global Market
Related Markets
Europe ai-based clinical trials solution provider market highlights
- The Europe ai-based clinical trials solution provider market generated a revenue of USD 376.3 million in 2021.
- The market is expected to grow at a CAGR of 21.8% from 2022 to 2030.
- In terms of segment, oncology was the largest revenue generating therapeutic applications in 2021.
- CVD is the most lucrative therapeutic applications segment registering the fastest growth during the forecast period.
- Country-wise, France is expected to register the highest CAGR from 2022 to 2030.
Europe data book summary
| Market revenue in 2021 | USD 376.3 million |
| Market revenue in 2030 | USD 2,225.2 million |
| Growth rate | 21.8% (CAGR from 2021 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | CVD |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
| Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.5% of the global ai-based clinical trials solution provider market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,944.1 million by 2030.
Countries such as Germany and the UK have a substantially large patient pool and advanced medical expertise. The doctors advocate for clinical trials, thus increasing patient recruitment and benefiting research and patients. This acceptance and support from medical fraternity have led to increase in the adoption of patient friendly as well as technologically advanced clinical trial solutions in the European region.
In addition, legal aspects are in a developing stage in Germany, but are fully evolved in the UK and France. The regulations are formulated to ensure safety, rights, and proper reimbursement of volunteers. With clearer protocols and increased funding, Europe is expected to be a promising region for clinical trials.
Moreover, other factors such as greater access to treatment-naïve patient pool, higher concentration of patients near sites, cheap labor costs, and close relationship between doctors & patients are driving AI-based clinical trials solution providers market growth in Europe.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Artificial Intelligence Based Clinical Trials Solution Provider Market
Artificial Intelligence Based Clinical Trials Solution Provider Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Alphabet Inc Class A | View profile | 180,895 | 1600 Amphitheatre Parkway, Mountain View, CA, United States, 94043 | www.abc.xyz |
| Mendel.ai | View profile | 101-250 | San Jose, California, United States, North America | mendel.ai/ |
| The Carlyle Group Inc | View profile | 2,200 | 1001 Pennsylvania Avenue, NW, Washington, DC, United States, 20004-2505 | www.carlyle.com |
| Exscientia PLC ADR | View profile | 483 | Oxford Science Park, The Schrodinger Building, Oxford, United Kingdom, OX4 4GE | www.exscientia.ai |
| SAI.TECH Global Corp | View profile | 37 | 195 Pearl’s Hill Terrace, Number 01-05, Singapore, Singapore, 168976 | www.sai.tech |
| Median Technologies | View profile | 101-250 | Valbonne, Provence-Alpes-Cote d'Azur, France, Europe | www.mediantechnologies.com |
Europe artificial intelligence based clinical trials solution provider market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to AI-based Clinical Trials Solution Provider Market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.25% in 2021.
Horizon Databook has segmented the Europe ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Countries such as Germany and the UK have a substantially large patient pool and advanced medical expertise. The doctors advocate for clinical trials, thus increasing patient recruitment and benefiting research and patients. This acceptance and support from medical fraternity have led to increase in the adoption of patient friendly as well as technologically advanced clinical trial solutions in the European region.
In addition, legal aspects are in a developing stage in Germany, but are fully evolved in the UK and France. The regulations are formulated to ensure safety, rights, and proper reimbursement of volunteers. With clearer protocols and increased funding, Europe is expected to be a promising region for clinical trials.
Moreover, other factors such as greater access to treatment-naïve patient pool, higher concentration of patients near sites, cheap labor costs, and close relationship between doctors & patients are driving AI-based clinical trials solution providers market growth in Europe.
- Europe Ai-Based Clinical Trials Solution Provider Market Therapeutic Applications Outlook (Revenue, USD Million , 2018-2030)
- Oncology
- CVD
- Neurological Diseases or conditions
- Metabolic diseases
- Infectious diseases
- Others
- Europe Ai-Based Clinical Trials Solution Provider Market Clinical Trial Phase Outlook (Revenue, USD Million , 2018-2030)
- Phase-I
- Phase-II
- Phase-III
- Europe Ai-Based Clinical Trials Solution Provider Market End User Outlook (Revenue, USD Million , 2018-2030)
- Pharmaceutical Companies
- Academia
- Others
Reasons to subscribe to artificial intelligence based clinical trials solution provider market databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of artificial intelligence based clinical trials solution provider market databook
- Our clientele includes a mix of artificial intelligence based clinical trials solution provider market companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe artificial intelligence based clinical trials solution provider market, including forecasts for subscribers. This continent databook contains high-level insights into Europe artificial intelligence based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Europe Ai-Based Clinical Trials Solution Provider Market, 2018-2030 (US$M)
Europe artificial intelligence based clinical trials solution provider market statistics, by therapeutic applications, 2018-2030 (US$M)
